about
GVAX in Advanced Prostate Cancer Patients Made LymphopenicImmunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate CancerVaccine Therapy in Treating Patients With Metastatic Prostate CancerPROvenge Treatment and Early Cancer TreatmentVaccine Treatment for Hormone Refractory Prostate CancerTrial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate CancerPhase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate CancerSafety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory DiseaseAndrogen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate CancerRNActive®-Derived Therapeutic VaccineA Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate CancerA Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate CancerVaccine Therapy in Treating Patients With Metastatic, Progressive Prostate CancerStudy Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC PatientsSingle Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer PatientsAbiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to ChemotherapySipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate CancerA Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate CancerNatural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer PatientsDocetaxel Followed by Provenge in Metastatic Prostate CancerProvenge Followed by Docetaxel in Castration-Resistant Prostate CancerPembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With EnzalutamideEnzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate CancerPembrolizumab and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate CancerCombination Immunotherapy in Biochemically Recurrent Prostate CancerEnzalutamide With or Without Vaccine Therapy for Advanced Prostate CancerOlaparib and Radium Ra 223 Dichloride in Treating Men With Metastatic Castration-Resistant Prostate Cancer That Has Spread to the BoneA Phase 1 Clinical Study of AZD4635 and Durvalumab in Patients With Advanced Solid MalignanciesStudy Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPCProstvac in Patients With Biochemically Recurrent Prostate CancerTreatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy VaccinesA Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate CancerPhase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, ALT-803 and Epacadostat (QuEST1)Dendritic Cell Vaccine Study (DC/PC3) for Prostate CancerTo Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) AntigenSipuleucel-T as Neoadjuvant Treatment in Prostate CancerCollecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerHuman Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell VaccinesAutologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate CancerGTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy
P1050
Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndromeImpact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSUREDiet, nutrition, and avoidable cancerSecond malignancies after radiotherapy for prostate cancer: systematic review and meta-analysisClear cell urothelial carcinoma of the urinary bladder: a case report and review of the literatureIntraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder and prostate cancersThe urologic epithelial stem cell database (UESC) - a web tool for cell type-specific gene expression and immunohistochemistry images of the prostate and bladder.New acquisition protocol of 18F-choline PET/CT in prostate cancer patients: review of the literature about methodology and proposal of standardizationSolitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature.Superficial urothelial cancer in the prostatic urethra.The role of pelvic lymphadenectomy in the management of prostate and bladder cancer.Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis.Male pattern baldness and incidence of prostate cancer: A systematic review and meta-analysisModerate hypofractionated radiotherapy vs conventional fractionated radiotherapy in localized prostate cancer: a systemic review and meta-analysis from Phase III randomized trialsAndrogen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer PatientsEvaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate CancerEnzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)
P921
Q58405893-198B897C-1511-4410-BFB3-65D59EDC5987Q58407099-EB3AC358-64B6-4EAE-9522-D1B93CE88041Q58407314-62155021-80A1-44BD-93B3-B9EF0EFF09C6Q58407408-C038F7EE-6DAB-46F4-A9DE-01D19CF1FA0CQ58407430-5171AE69-262D-4548-9779-9D483E16F275Q58407436-05C67EA9-EC17-47DF-8A59-73E78B276967Q58407447-A27F0673-0C98-42EE-8264-768159E46FB0Q58407448-F411F8F1-C0EE-4F64-9B6B-BA6944B56DBEQ58407458-C766DDE3-C09E-4028-AF3D-B1F6790E6BCCQ58407482-96D9495F-8BBA-47BD-A5BF-536B4E5C9507Q58407483-2AF9DE93-7984-4191-8950-5290BE3EE7C6Q58407485-507AC096-B00A-4BB2-A25B-736AB0006461Q58407490-06AD21A6-63C6-4A78-AF42-29418AF778C2Q58407501-A6E4C359-C8B1-4924-8EF6-5DB43E950FE1Q58407510-81B31C3B-69A3-4AAA-9E36-42E9179638BAQ58407542-5B370234-C7F4-422E-B72B-08A9044B2121Q58407568-B70D8DAF-7166-4E1F-8DF6-6BB661AD15B4Q58407587-17149662-A472-4C07-A2A0-E1E91EE0ABD7Q58407590-ACCCB96C-4E85-4AA7-BD6D-FFEEA2A9BB8EQ58407616-A1BE0768-FB18-4370-A0EF-4850CD20050FQ58407618-93469B5F-7CB5-4C4D-8D45-D1E5E899E4FDQ58407646-5B3A706E-FF21-4272-BE9C-F28D6C60F443Q58407681-8A20AE6B-B3C5-406E-8F54-3156C80E4234Q58407704-E510AA18-AC5A-4F04-8DC0-C705B939F941Q58407706-3EBB0C07-B4E9-4EB0-8DB5-8877C99CC6E7Q58407724-C8B0A771-13DC-4A12-9BDE-0ADF2C73231CQ58407741-663DF195-E53C-4A62-B351-22CC60D34618Q58407755-CBE8F7E1-F81F-4852-A2B9-7B168DE825D3Q58407766-BB680F7B-AF03-4F74-9940-C1F1FE318186Q58407788-BA059E27-3E45-4D9C-BEF7-6739B613CB2BQ58407836-4FA1418E-8672-4649-8CF9-F29A750E8999Q58407838-CEFFC4E1-5EE2-457A-B73B-4618502730C2Q58407867-57FB6128-C999-4B40-89F0-714FC9E37463Q58844386-7CC1AFCB-44E9-42B0-96F6-05299BF5BEDCQ58844508-E53DADF9-6335-46F5-AB83-EE74701D582AQ58844517-7BDD7020-7F53-4855-81C8-B0077A912E68Q58844622-2497C867-B807-45BF-8F47-DE17FE27143FQ58844642-718AF97F-03F7-41EF-A107-F507F94D4B9EQ58844659-4BA2E503-89A8-4B17-8B05-9CDAEE0179FBQ58844871-562D243D-B7F3-4313-B31F-02914371F8FC
P1050
Q21090022-8024CF8E-AA91-4F8B-BFAA-90C21D580CACQ24170221-65cba330-4cdf-10a1-0d63-ee1c72c26145Q24554391-D9DD6534-1A48-4021-8FAB-88E0C6ACE04FQ26764960-08D10294-4CBA-414A-BAB5-A268942CCCCCQ26853298-5A516AD2-7222-4406-8004-D6F8F7E39DD9Q28559812-051BEC91-65FE-45CF-84B5-E7B7B779A07DQ33309753-35963625-27D8-424E-96CF-6554D82B6EC6Q38239699-E92BA75D-2231-4A1C-8C2A-A28D10A74D3FQ38460514-28F9F0A7-5094-4099-B779-2B84F6A220EBQ54965670-CD012609-F4E1-4B85-A83D-E9DB14260015Q55110163-34375E81-FA0F-4714-A84E-58E29D7DDF8DQ55154528-50193E64-DEAB-4089-A628-23F93713B0D9Q57110520-165032E9-5358-4602-ABD5-17B3BC52D8D8Q64228151-C2814645-19E1-41D0-9DB0-B6A4CF96ED22Q86286702-8693822F-E0A7-40EA-AF01-AC79625AAD80Q87077073-99E69257-5BC4-49E5-BC0E-281D281B5E77Q89507223-0F795D1F-794F-4AFE-A0E9-DF2F05646AF1
P921
description
neoplasm (disease) that involves the prostate gland
@en
name
prostate neoplasm
@en
tumeur de la prostate
@fr
неоплазма простаты
@ru
type
label
prostate neoplasm
@en
tumeur de la prostate
@fr
неоплазма простаты
@ru
altLabel
Neoplasm of Prostate
@en
Neoplasm of the Prostate
@en
Prostate Tumor
@en
Prostatic Neoplasm
@en
Prostatic Neoplasms
@en
Tumor of Prostate
@en
neoplasm of prostate gland
@en
prostate gland neoplasm (disease)
@en
prostate gland tumor
@en
tumor of prostate gland
@en
prefLabel
prostate neoplasm
@en
tumeur de la prostate
@fr
неоплазма простаты
@ru
P672
P486
P1748
P1995
P2892
P486
P5270
MONDO:0021259
P672
C04.588.945.440.770
C12.294.260.750
C12.294.565.625
C12.758.409.750